Type of diabetes-Type 2 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

Efficacy and safety of basal-bolus insulin vs glp-1 receptor agonist plus basal insulin in patients with uncontrolled type 2 diabetes

Posted by on Jun 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell This article compared the safety and effectiveness of insulin detemir (Levemir) plus liraglutide (Victoza) vs insulin detemir plus insulin aspart (Novolog) in the management of type 2 diabetes (T2D). The authors concluded that detemir plus liraglutide is a safe and more...

Read More

Ipragliflozin versus metformin for blood sugar control and fat reduction in type 2 diabetes

Posted by on May 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the effectiveness of ipragliflozin compared to metformin in improving blood sugar control and reducing fat on organs in patients with type 2 diabetes (T2D) treated with sitagliptin. The main finding of the study was that ipragliflozin had greater reductions in fat but metformin had better blood sugar...

Read More

Evaluating the safety and effectiveness of pioglitazone in type 2 diabetes

Posted by on Apr 24, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the safety and effectiveness of pioglitazone in the treatment of type 2 diabetes (T2D). The main finding of the study was that pioglitazone was an effective treatment of T2D. Some background Insulin is the hormone that controls blood sugar. In T2D, patients have insulin resistance. This means that...

Read More

Does empagliflozin help lower blood pressure in patients with diabetes and high night time blood pressure?

Posted by on Mar 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to monitor blood pressure changes with empagliflozin (Jardiance) treatment and normal blood pressure treatment in patients with type 2 diabetes (T2D) and uncontrolled night time high blood pressure. The main finding of the study was that these patients had reductions in their blood pressure when empagliflozin was...

Read More

Does canagliflozin increase the risk of bone fractures in patients with type 2 diabetes?

Posted by on Mar 7, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to investigate the effect of canagliflozin (Invokana) use on bone fracture risk in patients with type 2 diabetes (T2D). The main finding of the study was that there was no increased risk of bone fractures with canagliflozin use. Some background Canagliflozin is an SGLT-2 inhibitor, used to treat T2D. It works by...

Read More

Looking for patients with type 2 diabetes to test new treatment BTI320

Posted by on Feb 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study is the test the effectiveness of new drug BTI320 on blood glucose control in type 2 diabetes (T2D). The main outcome to be measured will be a change in blood glucose 2 hours after meals. This study is being carried out in the United States. The details The number of patients with T2D is constantly on the rise....

Read More

Diacerein reduces liver scarring in diabetic patients with non-alcoholic fatty liver disease

Posted by on Feb 15, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to investigate how effective diacerein is in reducing fat deposits and scarring on the liver in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). The main finding of the study was that diacerein reduced liver scarring in these patients. Some background T2D is commonly associated with...

Read More